Pathogenesis of the acute coronary syndromes and therapeutic implications

被引:25
作者
Badimon, L
Badimon, JJ
Vilahur, G
Segalés, E
Llorente, V
机构
[1] Hosp Santa Creu & Sant Pau, CSIC, ICCC, Cardiovasc Res Ctr, Barcelona 08034, Spain
[2] Mt Sinai Med Ctr, New York, NY 10029 USA
关键词
atherosclerosis; thrombosis; statins; fibrinolytics; heparin; anti-platelet agents; atherosclerotic plaque; unstable angina; myocardial infarction;
D O I
10.1159/000073571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis is characterized by the thickening and obstruction of the arterial lumen and thrombosis associated with vulnerable disrupted plaques seems to be responsable for the accelerated process of clinical sindrome presentation. Strategies to promote plaque stabilization and reduce thrombus burden have been one of the major targets of recent times. Modification of diet and lifestyle has important benefit in reducing coronary risk. Several pharmacological strategies for reducing cardiovascular. morbidity and mortality have demonstrated effectiveness. Statins and angiotensin converting enzyme, fibrinolitics, inhibitors of the intrinsic coagulation cascade and anti-platelet agents have been developed to reduce the impact of atherosclerosis and inhibit thrombogenesis. Copyright (C) 2002 S. Karger AG. Basel.
引用
收藏
页码:225 / 231
页数:7
相关论文
共 34 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]   Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction - TIMI 11B-ESSENCE meta-analysis [J].
Antman, EM ;
Cohen, M ;
Radley, D ;
McCabe, C ;
Rush, J ;
Premmereur, J ;
Braunwald, E .
CIRCULATION, 1999, 100 (15) :1602-1608
[3]   Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques - Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions [J].
Badimon, JJ ;
Lettino, M ;
Toschi, V ;
Fuster, V ;
Berrozpe, M ;
Chesebro, JH ;
Badimon, L .
CIRCULATION, 1999, 99 (14) :1780-1787
[4]  
BADIMON JJ, 1993, CIRCULATION, V87, P3
[5]  
BADIMON L, 2002, PLATELETS THROMBOTIC, P727
[6]   Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting - The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) [J].
Bertrand, ME ;
Rupprecht, HJ ;
Urban, P ;
Gershlick, AH .
CIRCULATION, 2000, 102 (06) :624-629
[7]   ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction [J].
Braunwald, E ;
Antman, EM ;
Beasley, JW ;
Califf, RM ;
Cheitlin, MD ;
Hochman, JS ;
Jones, RH ;
Kereiakes, D ;
Kupersmith, J ;
Levin, TN ;
Pepine, CJ ;
Schaeffer, JW ;
Smith, EE ;
Steward, DE ;
Theroux, P ;
Gibbons, RJ ;
Alpert, JS ;
Eagle, KA ;
Faxon, DP ;
Fuster, V ;
Gardner, TJ ;
Gregoratos, G ;
Russell, RO ;
Smith, SC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :970-1056
[8]  
Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427
[9]   Effects of lipid-lowering by simvastatin on human atherosclerotic lesions - A longitudinal study by high-resolution, noninvasive magnetic resonance imaging [J].
Corti, R ;
Fayad, ZA ;
Fuster, V ;
Worthley, SG ;
Helft, G ;
Chesebro, J ;
Mercuri, M ;
Badimon, JJ .
CIRCULATION, 2001, 104 (03) :249-252
[10]  
Corti R, 2002, AM HEART MONOGR S, P287